These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6692098)

  • 1. Calcitonin and carcino-embryonic antigen in the follow-up of patients with medullary carcinoma of the thyroid.
    Palmer BV; Harmer CL; Shaw HJ
    Br J Surg; 1984 Feb; 71(2):101-4. PubMed ID: 6692098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
    Miyauchi A; Onishi T; Matsuzuka F; Hirai K; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
    Gan No Rinsho; 1986 Oct; 32(12):1519-24. PubMed ID: 3783976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of circulating carcinoembryonic antigen and calcitonin in diagnosis of medullary thyroid carcinoma: a comparative study.
    Hamada S; Ishikawa N; Yoshi M; Morita R; Fukunaga M
    Endocrinol Jpn; 1976 Dec; 23(6):505-10. PubMed ID: 1022524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].
    Argémi B; Vagneur JP; Conforto C; Even F; Rollat MC; Simonin R
    Bull Cancer; 1984; 71(2):133-9. PubMed ID: 6733293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization and resection of clinically inapparent medullary carcinoma of the thyroid.
    Norton JA; Doppman JL; Brennan MF
    Surgery; 1980 Jun; 87(6):616-22. PubMed ID: 7376073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma.
    Busnardo B; Girelli ME; Simioni N; Nacamulli D; Busetto E
    Cancer; 1984 Jan; 53(2):278-85. PubMed ID: 6690009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of tumor markers in monitoring thyroid carcinoma].
    Gorgone S; Lazzara S; Palmeri R; Belnome N; Calbo L; Dattola P; Melita P
    Chir Ital; 1987 Feb; 39(1):87-95. PubMed ID: 3607983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between calcitonin and carcinoembryonic antigen levels in medullary carcinoma of the thyroid.
    Calmettes C; Moudktar MS; Milhaud G
    Biomedicine; 1977 Mar; 27(2):52-4. PubMed ID: 861349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoembryonic antigen and calcitonin as markers of malignancy in medullary thyroid carcinoma.
    Cox CE; VanVickle J; Froome LC; Mendelsohn G; Baylin SB; Wells SA
    Surg Forum; 1979; 30():120-1. PubMed ID: 395674
    [No Abstract]   [Full Text] [Related]  

  • 10. The values of calcitonin and carcinoembryonic antigen in the treatment and management of nonfamilial medullary thyroid carcinoma.
    Rougier P; Calmettes C; Laplanche A; Travagli JP; Lefevre M; Parmentier C; Milhaud G; Tubiana M
    Cancer; 1983 Mar; 51(5):855-62. PubMed ID: 6821852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tumor markers in C-cell cancer].
    Raue F; Schmidt-Gayk H; Ziegler R
    Dtsch Med Wochenschr; 1983 Feb; 108(8):283-7. PubMed ID: 6297868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of calcitonin and carcinoembryonic antigen (CEA) in medullary carcinoma of the thyroid (MCT) by immunoperoxidase technique.
    Talerman A; Lindeman J; Kievit-Tyson PA; Dröge-Droppert C
    Histopathology; 1979 Nov; 3(6):503-10. PubMed ID: 389771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.
    Barbet J; Campion L; Kraeber-Bodéré F; Chatal JF;
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6077-84. PubMed ID: 16091497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of calcitonin determination in the evaluation of completeness of thyroidectomy in medullary carcinoma of the thyroid gland].
    Wasylewski A; Skrzypek J; Kokot F; Sledziński Z
    Endokrynol Pol; 1981; 32(3):239-44. PubMed ID: 7308165
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of serum carcinoembryonic antigen in preoperative diagnosis of cancer in patients with thyroid nodules.
    Madeddu G; Langer M; Dettori G; Costanza C
    Cancer; 1980 May; 45(10):2607-10. PubMed ID: 7378994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medullary thyroid carcinoma surgical cytoreduction induces an increase in serum calcitonin and carcinoembryonic antigen doubling times.
    Papapetrou PD; Polymeris A
    Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):164-8. PubMed ID: 22328112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of serum calcitonin by immunometric two-site assays in normal subjects and patients with medullary thyroid carcinoma.
    Zink A; Blind E; Raue F
    Eur J Clin Chem Clin Biochem; 1992 Dec; 30(12):831-5. PubMed ID: 1489858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of long-term continuous subcutaneous octreotide administration in 14 patients with medullary thyroid carcinoma.
    Modigliani E; Cohen R; Joannidis S; Siame-Mourot C; Guliana JM; Charpentier G; Cassuto D; Bentata Pessayre M; Tabarin A; Roger P
    Clin Endocrinol (Oxf); 1992 Feb; 36(2):183-6. PubMed ID: 1568350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Calcitonin determination as a possibility for the evaluation of surgical result in medullary thyroid carcinoma (C-cell carcinoma)].
    Horn J; Pfarr B; Ziegler R
    Langenbecks Arch Chir; 1975; Suppl():231-4. PubMed ID: 1207235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.